Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
life sciences & biomedicine (7) 7
oncology (7) 7
science & technology (7) 7
breast cancer (5) 5
breast neoplasms - drug therapy (5) 5
breast neoplasms - pathology (5) 5
female (5) 5
chemotherapy (4) 4
adult (3) 3
aged (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast neoplasms - surgery (3) 3
clinical trials (3) 3
middle aged (3) 3
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols (2) 2
biological and medical sciences (2) 2
biological products (2) 2
biosimilar pharmaceuticals - therapeutic use (2) 2
breast (2) 2
breast neoplasms - chemistry (2) 2
cancer (2) 2
cancer therapies (2) 2
chemotherapy, adjuvant (2) 2
cyclophosphamide - administration & dosage (2) 2
fda approval (2) 2
fluorouracil - administration & dosage (2) 2
hematology, oncology and palliative medicine (2) 2
medical sciences (2) 2
medicine & public health (2) 2
neoadjuvant therapy (2) 2
neoplasm staging (2) 2
predictive value of tests (2) 2
receptor, erbb-2 - analysis (2) 2
retrospective studies (2) 2
surgery (2) 2
taxoids (2) 2
taxoids - administration & dosage (2) 2
trastuzumab (2) 2
1112 oncology and carcinogenesis (1) 1
abridged index medicus (1) 1
adenocarcinoma (1) 1
adenocarcinoma - chemistry (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adjuvant treatment (1) 1
animals (1) 1
anthracycline (1) 1
antibodies, monoclonal - pharmacology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antimitotic agents (1) 1
antineoplastic agents - chemistry (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
area under curve (1) 1
availability (1) 1
bcl-2 (1) 1
biochemistry, general (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - metabolism (1) 1
biopsy - methods (1) 1
biosimilar pharmaceuticals (1) 1
biosimilar pharmaceuticals - administration & dosage (1) 1
biosimilar pharmaceuticals - adverse effects (1) 1
biosimilar pharmaceuticals - chemistry (1) 1
bone marrow (1) 1
breast neoplasms (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - immunology (1) 1
breast neoplasms - metabolism (1) 1
capecitabine (1) 1
carrier proteins - biosynthesis (1) 1
cell division - physiology (1) 1
cells, cultured (1) 1
ceramides - genetics (1) 1
ceramides - metabolism (1) 1
chi-square distribution (1) 1
circulating tumor cells (1) 1
clinical medicine (1) 1
clinical trials as topic (1) 1
comparative analysis (1) 1
cop9 signalosome complex (1) 1
cost control (1) 1
cost reduction (1) 1
cyclin-dependent kinase inhibitor p27 (1) 1
cyclin-dependent kinase inhibitor p27 - metabolism (1) 1
cyclophosphamide (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
dinoprostone - physiology (1) 1
disease-free survival (1) 1
dna-binding proteins - biosynthesis (1) 1
docetaxel (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial
by Stebbing, Justin, Prof and Baranau, Yauheni, MD and Baryash, Valeriy, MD and Manikhas, Alexey, MD and Moiseyenko, Vladimir, Prof and Dzagnidze, Giorgi, MD and Zhavrid, Edvard, Prof and Boliukh, Dmytro, MD and Stroyakovskii, Daniil, MD and Pikiel, Joanna, MD and Eniu, Alexandru, MD and Komov, Dmitry, MD and Morar-Bolba, Gabriela, MD and Li, Rubi K, MD and Rusyn, Andriy, Prof and Lee, Sang Joon, PhD and Lee, Sung Young, MS and Esteva, Francisco J, Prof
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 917 - 928
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Mastectomy | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Adenocarcinoma - chemistry | Biosimilar Pharmaceuticals - therapeutic use | Biosimilar Pharmaceuticals - administration & dosage | Double-Blind Method | Trastuzumab - adverse effects | Trastuzumab - administration & dosage | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Biosimilar Pharmaceuticals - adverse effects | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Receptor, ErbB-2 - analysis | Neoplasm Staging | Adenocarcinoma - surgery | Antimitotic agents | Medical colleges | Adjuvant treatment | Clinical trials | Breast cancer | Product development | Comparative analysis | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials
by Juul, Nicolai, MSc and Szallasi, Zoltan, Prof and Eklund, Aron C, MSc and Li, Qiyuan, MSc and Burrell, Rebecca A, BA and Gerlinger, Marco, MD and Valero, Vicente, MD and Andreopoulou, Eleni, MD and Esteva, Francisco J, Prof and Symmans, W Fraser, Prof and Desmedt, Christine, PhD and Haibe-Kains, Benjamin, PhD and Sotiriou, Christos, MD and Pusztai, Lajos, Prof and Swanton, Charles, Dr
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 4, pp. 358 - 365
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Multivariate Analysis | Predictive Value of Tests | Ceramides - metabolism | Drug Screening Assays, Antitumor - methods | Paclitaxel - pharmacology | Area Under Curve | Humans | Middle Aged | Metagenomics - methods | Antineoplastic Combined Chemotherapy Protocols | Logistic Models | Mitosis - genetics | Breast Neoplasms - drug therapy | Ceramides - genetics | Breast Neoplasms - genetics | RNA Interference | Breast Neoplasms - pathology | Adult | Female | Neoadjuvant Therapy | Aged | Models, Genetic | Retrospective Studies | Paclitaxel - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Tumor Markers in ovarian cancer
by Duffy, Michael J and Esteva, Francisco J and Harbeck, Nadia and Hayes, Daniel F and Molina, Rafael
Acta bioquímica clínica latinoamericana, ISSN 0325-2957, 03/2014, Volume 48, Issue 1, pp. 88 - 106
Life Sciences & Biomedicine | Medical Laboratory Technology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Detection and clinical implications of occult systemic micrometastatic breast cancer
by Kwa, Maryann and Esteva, Francisco J
08/2017, ISBN 0323359558
Micrometastasis | Liquid biopsy | Breast cancer | Circulating tumor cells
Book Chapter
Details down arrow
5. Are Biosimilars the Future of Oncology and Haematology?
by Zinzani, Pier Luigi and Dreyling, Martin and Gradishar, William and Andre, Marc and Esteva, Francisco J and Boulos, Suliman and Barca, Eva Gonzalez and Curigliano, Giuseppe
Drugs (New York, N.Y.), ISSN 0012-6667, 10/2019, Volume 79, Issue 15, pp. 1609 - 1624
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Medical Oncology | Biosimilar Pharmaceuticals - therapeutic use | Humans | Biosimilar Pharmaceuticals - chemistry | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - chemistry | Neoplasms - drug therapy | Drugs | Market entry | Insurance policies | Health services | Cost reduction | Clinical trials | Licenses | Oncology | Cancer therapies | Regulatory approval | Pathways | Immunotherapy | Safety | Availability | Biological products | Hematology | Litigation | Pharmacology | FDA approval | Patients | Cost control | Generic drugs | Chemotherapy | Immunogenicity | Clinical medicine | Pharmacokinetics | Cancer | Index Medicus
Journal Article
Details down arrow
6. Full Text Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy
by Buchholz, Thomas A and Davis, Darren W and McConkey, David J and Symmans, W. Fraser and Valero, Vicente and Jhingran, Anuja and Tucker, Susan L and Pusztai, Lajos and Cristofanilli, Massimo and Esteva, Francisco J and Hortobagyi, Gabriel N and Sahin, Aysegul A
The cancer journal (Sudbury, Mass.), ISSN 1528-9117, 01/2003, Volume 9, Issue 1, pp. 33 - 41
Bcl-2 | Breast cancer | Doxorubicin | Docetaxel | Apoptosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | In Situ Nick-End Labeling | Neoplasm, Residual - pathology | Biopsy - methods | Breast Neoplasms - surgery | Doxorubicin - therapeutic use | Predictive Value of Tests | Prospective Studies | Neoplasm, Residual - surgery | Apoptosis - drug effects | Humans | Middle Aged | Paclitaxel - analogs & derivatives | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Proto-Oncogene Proteins c-bcl-2 - metabolism | Taxoids | Time Factors | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoplasm, Residual - drug therapy | Biomarkers, Tumor - metabolism | Adult | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Mechanisms of disease: Understanding resistance to HER2-targeted therapy in human breast cancer
by Nahta, Rita and Yu, Dihua and Hung, Mien-Chie and Hortobagyi, Gabriel N and Esteva, Francisco J
Nature clinical practice. Oncology, ISSN 1743-4254, 05/2006, Volume 3, Issue 5, pp. 269 - 280
Breast | PTEN | P27 | IGF-1R | Trastuzumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - immunology | Neoplasm Invasiveness | Antibodies, Monoclonal - pharmacology | Humans | Receptor, ErbB-2 - metabolism | PTEN Phosphohydrolase - metabolism | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Phosphatidylinositol 3-Kinases - metabolism | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Cyclin-Dependent Kinase Inhibitor p27 - metabolism | Signal Transduction - immunology | Breast Neoplasms - pathology | Receptor, IGF Type 1 - immunology | Female | Antineoplastic Agents - pharmacology | Membrane Proteins - metabolism | Receptor, ErbB-2 - immunology | Protein Kinase Inhibitors - metabolism
Journal Article
Details down arrow
8. Full Text Can Early Response Assessment Guide Neoadjuvant Chemotherapy in Early-Stage Breast Cancer?
by Esteva, Francisco J and Hortobagyi, Gabriel N
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 4/2008, Volume 100, Issue 8, pp. 521 - 523
Life Sciences & Biomedicine | Oncology | Science & Technology | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Vinblastine - administration & dosage | Dose-Response Relationship, Drug | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Vinblastine - analogs & derivatives | Mastectomy, Segmental | Female | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Fluorouracil - analogs & derivatives | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Treatment Outcome | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Receptor, ErbB-2 - analysis | Neoplasm Staging | Research Design | Deoxycytidine - analogs & derivatives | Clinical trials | Chemotherapy | Breast cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions
by Ivan, Doina and Diwan, A Hafeez and Esteva, Francisco J and Prieto, Victor G
Modern pathology, ISSN 0893-3952, 07/2004, Volume 17, Issue 7, pp. 811 - 818
Immunohistochemistry | Melanoma - metabolism | Prognosis | Carrier Proteins - biosynthesis | Humans | Intracellular Signaling Peptides and Proteins | COP9 Signalosome Complex | Transcription Factors - biosynthesis | Melanocytes - chemistry | Melanoma - pathology | Chi-Square Distribution | Cyclin-Dependent Kinase Inhibitor p27 | Neoplasm Metastasis | Nevus - pathology | Melanocytes - pathology | Peptide Hydrolases | Retrospective Studies | DNA-Binding Proteins - biosynthesis | Nevus - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Effect of Growth Factors and Prostaglandin E2 on Restitution and Proliferation of Rabbit Esophageal Epithelial Cells
by Jimenez, Pilar and Lanas, Angel and Piazuelo, Elena and Esteva, Francisco
Digestive diseases and sciences, ISSN 0163-2116, 10/1998, Volume 43, Issue 10, pp. 2309 - 2316
Biochemistry, general | GROWTH FACTORS | Medicine & Public Health | ESOPHAGUS | Hepatology | Gastroenterology | Oncology | Transplant Surgery | WOUND REPAIR | Wound repair | Growth factors | Esophagus | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Rabbits | Dinoprostone - physiology | Epidermal Growth Factor - physiology | Cells, Cultured | Transforming Growth Factor beta - physiology | Tritium | Cell Division - physiology | Mucous Membrane - cytology | Animals | Insulin-Like Growth Factor I - physiology | Growth Substances - physiology | Hepatocyte Growth Factor - physiology | Wound Healing - physiology | Epithelial Cells - cytology | Esophagus - cytology | Thymidine - metabolism | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Effect of growth factors and prostaglandin E^sub 2^ on restitution and proliferation of rabbit esophageal epithelial cells
by Pilar Jimenez and Angel Lanas and Elena Piazuelo and Francisco Esteva
Digestive diseases and sciences, ISSN 0163-2116, 10/1998, Volume 43, Issue 10, p. 2309
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.